Terms: = Uterine cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
560 results:
1. Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer.
Lindemann K; Kildal W; Kleppe A; Tobin KAR; Pradhan M; Isaksen MX; Vlatkovic L; Danielsen HE; Kristensen GB; Askautrud HA
Eur J Cancer; 2024 Mar; 200():113584. PubMed ID: 38330767
[TBL] [Abstract] [Full Text] [Related]
2. New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.
Bruchim I; Capasso I; Polonsky A; Meisel S; Salutari V; Werner H; Lorusso D; Scambia G; Fanfani F
Expert Opin Ther Targets; 2024; 28(1-2):29-43. PubMed ID: 38327111
[TBL] [Abstract] [Full Text] [Related]
3. A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
Chiba Y; Kagabu M; Osakabe M; Ito R; Sato S; Takatori E; Kaido Y; Nagasawa T; Shoji T; Yanagawa N; Baba T
Jpn J Clin Oncol; 2024 Apr; 54(4):424-433. PubMed ID: 38251744
[TBL] [Abstract] [Full Text] [Related]
4. Specific Pathology Features Enrich Selection of Endometrial Carcinomas for POLE Testing.
Keyhanian K; Han L; Howitt BE; Longacre T
Am J Surg Pathol; 2024 Mar; 48(3):292-301. PubMed ID: 38062789
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
6. Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B.
Hao S; Meng Q; Sun H; Yang X; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Mol Carcinog; 2024 Feb; 63(2):339-355. PubMed ID: 37988232
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics and outcomes of surgically staged multiple classifier endometrial cancer.
Bogani G; Betella I; Multinu F; Casarin J; GhezzI F; Sorbi F; VizziellI G; Petrillo M; Cianci S; Berretta R; PaolinI B; FanfanI F; De Vitis L; Scambia G; Mariani A; Colombo N; Raspagliesi F
Eur J Surg Oncol; 2024 Jan; 50(1):107269. PubMed ID: 37984242
[TBL] [Abstract] [Full Text] [Related]
8. Molecular-based classification of endometrial carcinoma in Northern Thailand: impact on prognosis and potential for implementation in resource-limited settings.
Dankai W; Pongsuvareeyakul T; Phinyo P; Tejamai C; Teerapakpinyo C; Cheewakriangkrai C; Lekawanvijit S; Siriaunkgul S; Khunamornpong S
BMC Womens Health; 2023 Nov; 23(1):605. PubMed ID: 37964201
[TBL] [Abstract] [Full Text] [Related]
9. A bioinformatic analysis of the role of tp53 status on the infiltration of CD8+ T cells into the tumor microenvironment.
El-Arabey AA; Abdel-Hamied HE; Awadalla ME; Alosaimi B; Almanaa TN; Al-Shouli ST; Modafer YA; Alhamdi HW; Abdalla M
Braz J Med Biol Res; 2023; 56():e12970. PubMed ID: 37878888
[TBL] [Abstract] [Full Text] [Related]
10. Validation of Modaplex POLE mutation assay in endometrial carcinoma.
Dorca E; Velasco A; Varela M; Gatius S; Villatoro S; Fullana N; Cuevas D; Vaquero M; Birnbaum A; Neumann K; Matias-Guiu X
Virchows Arch; 2023 Dec; 483(6):787-794. PubMed ID: 37874375
[TBL] [Abstract] [Full Text] [Related]
11. Identification of the prognostic immune subtype in copy-number high endometrial cancer.
Mao M; Jiang F; Han R; Xiang Y
J Gynecol Oncol; 2024 Jan; 35(1):e8. PubMed ID: 37857563
[TBL] [Abstract] [Full Text] [Related]
12. Is HPV-negative cervical carcinoma a different type of cervical cancer?
Kulhan M; Bilgi A; Avci F; Ucar MG; Celik C; Kulhan NG
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9205-9212. PubMed ID: 37843334
[TBL] [Abstract] [Full Text] [Related]
13. PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial.
Loukovaara M; Bützow R; Staff S; Mäenpää M; Faltinová M; Lassus H; Veijalainen O; Grönvall M; Vaalavirta L; Kuikka E; Haataja M; Urpilainen E; Simojoki M; Anttila M; Auranen A
Int J Gynecol Cancer; 2023 Nov; 33(11):1807-1811. PubMed ID: 37813479
[TBL] [Abstract] [Full Text] [Related]
14. Is HOXA5 a Novel Prognostic Biomarker for uterine Corpus Endometrioid Adenocarcinoma?
Song C; Kim KB; Lee GS; Shin S; Kim B
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834206
[TBL] [Abstract] [Full Text] [Related]
15. UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion.
Ma S; Chen Q; Li X; Fu J; Zhao L
Sci Rep; 2023 Oct; 13(1):16899. PubMed ID: 37803076
[TBL] [Abstract] [Full Text] [Related]
16. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic Elongated and Fragmented Pattern.
Ju B; Wu J; Sun L; Yang C; Yu H; Hao Q; Wang J; Zhang H
Int J Gynecol Pathol; 2024 May; 43(3):233-241. PubMed ID: 37733028
[TBL] [Abstract] [Full Text] [Related]
18. Genomic profile of Chinese patients with endometrial carcinoma.
Li J; Li X; Quan C; Li X; Wan C; Wu X
BMC Cancer; 2023 Sep; 23(1):888. PubMed ID: 37730563
[TBL] [Abstract] [Full Text] [Related]
19. Endometrial adenocarcinoma recurring in the lung: impact of molecular profile and role of local therapies on prognosis.
Luzarraga Aznar A; Bebia V; López-Gil C; Giraldo A; Montoya MP; Verges R; Jauregui A; Castellvi J; Pérez-Benavente A; Colás E; Gil-Moreno A; Cabrera S
Int J Gynecol Cancer; 2023 Oct; 33(10):1564-1571. PubMed ID: 37726197
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of patients with endometrial carcinoma using the ProMise classifier: a pilot study from India.
Dahiya A; Rajadurai A; Daniel S; Sebastian A; Thomas DS; Thomas V; George R; Ram TS; Sathyamurthy A; Rebekah G; Peedicayil A; Pai R; Thomas A
Arch Gynecol Obstet; 2024 Apr; 309(4):1499-1508. PubMed ID: 37707553
[TBL] [Abstract] [Full Text] [Related]
[Next]
